BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2272655)

  • 1. Anti-stress activity in a muramyl-dipeptide.
    Singh N; Jain RK; Gupta CM; Anand N
    Indian J Exp Biol; 1990 Jul; 28(7):686-7. PubMed ID: 2272655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
    Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
    J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-infectious activity of liposomal muramyl dipeptides in immunodeficient CBA/N mice.
    Phillips NC; Chedid L
    Infect Immun; 1987 Jun; 55(6):1426-30. PubMed ID: 3553001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement in anti-Semliki Forest virus activity of ds RNA by a muramyl dipeptide.
    George CX; Jain RK; Gupta CM; Anand N
    FEBS Lett; 1986 May; 200(1):37-41. PubMed ID: 2422061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT
    Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Muramyl dipeptide derivatives in experimental and clinical use].
    Kaliuzhin OV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):104-8. PubMed ID: 9532704
    [No Abstract]   [Full Text] [Related]  

  • 7. [The immunostimulating activity of muramyl dipeptide and its derivatives].
    Karsonova MI; Andronova TM; Pinegin BV; Khaitov RM
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):104-10. PubMed ID: 10852007
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.
    Fraser-Smith EB; Matthews TR
    Infect Immun; 1981 Dec; 34(3):676-83. PubMed ID: 7333666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep-promoting effects of muramyl peptides.
    Krueger JM; Pappenheimer JR; Karnovsky ML
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6102-6. PubMed ID: 6964403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
    Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
    Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimetastatic effect of a liposome-entrapped synthetic analog of muramyl dipeptide].
    Umanskiĭ VIu; Stefanov AV; Los' GV; Andronova TM; Balitskiĭ KP
    Dokl Akad Nauk SSSR; 1986; 286(2):474-6. PubMed ID: 3004870
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of N-(2-acetamido-2,3-dideoxy-D-glucopyranos-3-yl)glycyl-L-alanyl-D -isoglutamine analogues of muramyl dipeptide.
    Calvo-Mateo A; De Las Heras FG
    Carbohydr Res; 1986 Nov; 155():266-71. PubMed ID: 3791300
    [No Abstract]   [Full Text] [Related]  

  • 14. The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues.
    Lopez-Berestein G; Mehta K; Mehta R; Juliano RL; Hersh EM
    J Immunol; 1983 Apr; 130(4):1500-2. PubMed ID: 6300230
    [No Abstract]   [Full Text] [Related]  

  • 15. New developments in the field of synthetic muramyl peptides, especially as adjuvants for synthetic vaccines.
    Lederer E
    Drugs Exp Clin Res; 1986; 12(6-7):429-40. PubMed ID: 3527628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of neo-glycosylated L-alanyl-D-isoglutamine derivatives as potential immunoadjuvants.
    Siedler F; Rudolph S; Musiol HJ; Moroder L
    Pept Res; 1992; 5(1):39-47. PubMed ID: 1623302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of novel derivatives of muramyl dipeptide on the immune system].
    Kaliuzhin OV; Fuks BB; Bovin NV; Zemliakov AE; Chirva VIa
    Biull Eksp Biol Med; 1994 May; 117(5):510-3. PubMed ID: 9296705
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement by muramyl peptides of the protective response of interferon-alpha/beta against encephalomyocarditis virus infection.
    Pouillart PR; Audibert FM; Chedid LA; Lefrancier PL; Bahr GM
    Int J Immunopharmacol; 1996 Mar; 18(3):183-92. PubMed ID: 8796446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of synthetic muramyl dipeptide derivatives on staphylococcal infection in mice].
    Grabchenko NI; Karpov AV; Chirva VIa; Tkachikova L; Spivak NIa
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (3):50-3. PubMed ID: 11550560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analogues of muramyl dipeptide (MDP) and tuftsin limit infection and inflammation in murine model of sepsis.
    Wardowska A; Dzierzbicka K; Szaryńska M; Dabrowska-Szponar M; Wiśniewska K; Myśliwski A; Trzonkowski P
    Vaccine; 2009 Jan; 27(3):369-74. PubMed ID: 19027810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.